{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:24:48Z","timestamp":1794561888255,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003188","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003189","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymgme.2026.110159","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:48:17Z","timestamp":1779029297000},"page":"110159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis"],"prefix":"10.1016","volume":"148","author":[{"given":"Pamela","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precilla","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Dietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Duque","family":"Lasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Powers","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia I.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110159_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 gangliosidosis-a mini-review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2026.110159_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 Gangliosidosis: mechanisms and management","volume":"14","author":"Rha","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ymgme.2026.110159_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.110159_bb0020","first-page":"663","article-title":"The GM1 and GM2 Gangliosidoses: natural history and Progress toward therapy","volume":"13","author":"Regier","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2026.110159_bb0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","article-title":"The natural history of type 1 infantile GM1 gangliosidosis: a literature-based meta-analysis","volume":"129","author":"Lang","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110159_bb0030","first-page":"127","article-title":"GM1 and GM2-Gangliosidosis: clinical features, neuroimaging findings and electroencephalography","volume":"18","author":"Karimzadeh","year":"2024","journal-title":"Iran. J. Child Neurol."},{"key":"10.1016\/j.ymgme.2026.110159_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.braindev.2018.01.009","article-title":"Diagnostic challenge for the rare lysosomal storage disease: late infantile GM1 gangliosidosis","volume":"40","author":"Lee","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2026.110159_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101318","article-title":"Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum beta-galactosidase activity in patients with GM1-gangliosidosis","volume":"32","author":"Quadrini","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2026.110159_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jimd.12269","article-title":"Detection of GM1-gangliosidosis in newborn dried blood spots by enzyme activity and biomarker assays using tandem mass spectrometry","volume":"44","author":"Su","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110159_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0887-8994(94)90129-5","article-title":"Normal serum beta-galactosidase in juvenile GM1 gangliosidosis","volume":"10","author":"Ishii","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2026.110159_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1212\/WNL.0b013e31825f047a","article-title":"Exome sequencing as a diagnostic tool in a case of undiagnosed juvenile-onset GM1-Gangliosidosis","volume":"79","author":"Pierson","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.110159_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24967","article-title":"The challenges in the interpretation of genetic variants detected by genomics techniques in patients with congenital anomalies","volume":"37","author":"Vaseghi","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ymgme.2026.110159_bb0065","article-title":"Clinical and genetic analysis of a Chinese family with GM1 gangliosidosis caused by a novel mutation in GLB1 gene","volume":"13","author":"Zhang","year":"2025","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110159_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70176","article-title":"Evaluation of the landscape of Pharmacodynamic biomarkers in GM1 and GM2 Gangliosidosis","volume":"18","author":"Stern","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ymgme.2026.110159_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70134","article-title":"From molecule to meaning: Neuronopathic biomarkers and clinical relevance in GM1","volume":"49","author":"Casazza","year":"2026","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110159_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymgme.2021.08.006","article-title":"Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry","volume":"134","author":"Mak","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110159_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107685","article-title":"Endogenous, non-reducing end glycosaminoglycan biomarkers for the mucopolysaccharidoses: accurate diagnosis and elimination of false positive newborn screening results","volume":"140","author":"Saville","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110159_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13023-020-01662-8","article-title":"A new UHPLC-MS\/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders","volume":"16","author":"Semeraro","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110159_bb0095","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/clinchem\/44.12.2422","article-title":"Identification of urinary oligosaccharides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"44","author":"Klein","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2026.110159_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ab.2005.06.042","article-title":"Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides","volume":"345","author":"Ramsay","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2026.110159_bb0105","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1373\/clinchem.2012.201053","article-title":"Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases","volume":"59","author":"Xia","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2026.110159_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-9-19","article-title":"Fast urinary screening of oligosaccharidoses by MALDI-TOF\/TOF mass spectrometry","volume":"9","author":"Bonesso","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110159_bb0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/rcm.7860","article-title":"Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses","volume":"31","author":"Piraud","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ymgme.2026.110159_bb0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0009-8981(79)90221-3","article-title":"An improved thin-layer chromatographic method for urinary oligosaccharide screening","volume":"92","author":"Sewell","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2026.110159_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104627","article-title":"A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis","volume":"92","author":"Kell","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2026.110159_bb0130","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa2510935","article-title":"AAV9 gene therapy in type II GM1 gangliosidosis - a phase 1\u20132 trial","volume":"394","author":"Lewis","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110159_bb0135","series-title":"M10 Bioanalytical Method Validation and Study Sample Analysis Guidance for Industry","author":"FDA","year":"2022"},{"key":"10.1016\/j.ymgme.2026.110159_bb0140","series-title":"Bioanalytical Method Validation for Biomarkers Guidance for Industry","author":"FDA","year":"2026"},{"key":"10.1016\/j.ymgme.2026.110159_bb0145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4155\/bio.13.323","article-title":"A clinical biomarker assay for the quantification of d3-creatinine and creatinine using LC-MS\/MS","volume":"6","author":"Leonard","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ymgme.2026.110159_bb0150","series-title":"Genetic Syndromes: A Comprehensive Reference Guide","first-page":"1","article-title":"GM1 Gangliosidosis","author":"Senarathne","year":"2020"},{"key":"10.1016\/j.ymgme.2026.110159_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53995-5","article-title":"Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content","volume":"9","author":"Tonin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.110159_bb0160","article-title":"Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients","volume":"30","author":"Welford","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110159_bb0165","article-title":"Characterization of glycan substrates accumulating in GM1 gangliosidosis","volume":"21","author":"Lawrence","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110159_bb0170","first-page":"540","article-title":"Beta-galactosidase deficiency in the GLB1 spectrum of lysosomal storage disease can present with severe muscle weakness and atrophy","volume":"63","author":"Pedersen","year":"2022","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110159_bb0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1399-0004.1976.tb01608.x","article-title":"Mucolipidosis II and III: different residual activity of beta-galactosidase in cultured fibroblasts","volume":"9","author":"Leroy","year":"1976","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2026.110159_bb0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1073\/pnas.95.2.621","article-title":"The atomic model of the human protective protein\/cathepsin a suggests a structural basis for galactosialidosis","volume":"95","author":"Rudenko","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.110159_bb0185","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ymthe.2022.03.004","article-title":"Durability of transgene expression after rAAV gene therapy","volume":"30","author":"Muhuri","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110159_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/20406207251406537","article-title":"Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expression","volume":"17","author":"Fong","year":"2026","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.ymgme.2026.110159_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1392683","article-title":"Therapeutic developments for neurodegenerative GM1 gangliosidosis","volume":"18","author":"Foster","year":"2024","journal-title":"Front. Neurosci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:24:25Z","timestamp":1794558265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1096719226004427"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110159","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110159"}}